Efecto inmunosupresor in vitro de las lipoproteínas de baja densidad

Background: Immune cells participate in the formation of atheromatous plate, however little is known about the effects of native or oxidatively modified lipoproteins on these cells. Aim: To study the effects of lipoproteins on in vitro mononuclear cell proliferation. Material and methods: Peripheral...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: González R,Margarita, Sanz C,Ivette, Rojas S,Nina, Silva F,Víctor, Kirsten L,Lilian, Bustamante C,Marcelo
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 1999
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98871999001100003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98871999001100003
record_format dspace
spelling oai:scielo:S0034-988719990011000032005-11-23Efecto inmunosupresor in vitro de las lipoproteínas de baja densidadGonzález R,MargaritaSanz C,IvetteRojas S,NinaSilva F,VíctorKirsten L,LilianBustamante C,Marcelo Atherosclerosis Lipoproteins Lipoproteins, LDL Lymphocyte transformation Background: Immune cells participate in the formation of atheromatous plate, however little is known about the effects of native or oxidatively modified lipoproteins on these cells. Aim: To study the effects of lipoproteins on in vitro mononuclear cell proliferation. Material and methods: Peripheral blood mononuclear cells were obtained from 10 patients with type 2 diabetes mellitus (aged 52 ± 9 years old with a disease duration of 8.2 ± 5.7 years and a mean glycosilated hemoglobin of 9.3 ± 2.2%) and 10 non diabetic healthy controls (aged 50.3 ± 7.1 years old). These were stimulated with phytohemagglutinin (PHA) alone or in the presence of native LDLS, malondialdehyde modified LDLs or glycated LDLs. Proliferation was measured as 3H-thymidine incorporation and expressed as Stimulation Index (SI). Results: SI of patients and healthy subjects, after PHA stimulation were similar: (57.5 ± 29.8 and 61.1 ± 23.5) respectively LDLs did not induce proliferation in neither group. Native LDLs produced a 98% inhibition of PHA induced proliferation. Malondialdehyde modified and glycated LDLs caused a 50% inhibition. The suppressive effect was maintained when lipoproteins were incorporated to culture media 60 min prior or after PHA stimulation. Conclusions: Lipoproteins inhibit in vitro PHA induced peripheral blood mononuclear cell proliferation both in diabetic and in non diabetic subjects.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.127 n.11 19991999-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98871999001100003es10.4067/S0034-98871999001100003
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Atherosclerosis
Lipoproteins
Lipoproteins, LDL
Lymphocyte transformation
spellingShingle Atherosclerosis
Lipoproteins
Lipoproteins, LDL
Lymphocyte transformation
González R,Margarita
Sanz C,Ivette
Rojas S,Nina
Silva F,Víctor
Kirsten L,Lilian
Bustamante C,Marcelo
Efecto inmunosupresor in vitro de las lipoproteínas de baja densidad
description Background: Immune cells participate in the formation of atheromatous plate, however little is known about the effects of native or oxidatively modified lipoproteins on these cells. Aim: To study the effects of lipoproteins on in vitro mononuclear cell proliferation. Material and methods: Peripheral blood mononuclear cells were obtained from 10 patients with type 2 diabetes mellitus (aged 52 ± 9 years old with a disease duration of 8.2 ± 5.7 years and a mean glycosilated hemoglobin of 9.3 ± 2.2%) and 10 non diabetic healthy controls (aged 50.3 ± 7.1 years old). These were stimulated with phytohemagglutinin (PHA) alone or in the presence of native LDLS, malondialdehyde modified LDLs or glycated LDLs. Proliferation was measured as 3H-thymidine incorporation and expressed as Stimulation Index (SI). Results: SI of patients and healthy subjects, after PHA stimulation were similar: (57.5 ± 29.8 and 61.1 ± 23.5) respectively LDLs did not induce proliferation in neither group. Native LDLs produced a 98% inhibition of PHA induced proliferation. Malondialdehyde modified and glycated LDLs caused a 50% inhibition. The suppressive effect was maintained when lipoproteins were incorporated to culture media 60 min prior or after PHA stimulation. Conclusions: Lipoproteins inhibit in vitro PHA induced peripheral blood mononuclear cell proliferation both in diabetic and in non diabetic subjects.
author González R,Margarita
Sanz C,Ivette
Rojas S,Nina
Silva F,Víctor
Kirsten L,Lilian
Bustamante C,Marcelo
author_facet González R,Margarita
Sanz C,Ivette
Rojas S,Nina
Silva F,Víctor
Kirsten L,Lilian
Bustamante C,Marcelo
author_sort González R,Margarita
title Efecto inmunosupresor in vitro de las lipoproteínas de baja densidad
title_short Efecto inmunosupresor in vitro de las lipoproteínas de baja densidad
title_full Efecto inmunosupresor in vitro de las lipoproteínas de baja densidad
title_fullStr Efecto inmunosupresor in vitro de las lipoproteínas de baja densidad
title_full_unstemmed Efecto inmunosupresor in vitro de las lipoproteínas de baja densidad
title_sort efecto inmunosupresor in vitro de las lipoproteínas de baja densidad
publisher Sociedad Médica de Santiago
publishDate 1999
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98871999001100003
work_keys_str_mv AT gonzalezrmargarita efectoinmunosupresorinvitrodelaslipoproteinasdebajadensidad
AT sanzcivette efectoinmunosupresorinvitrodelaslipoproteinasdebajadensidad
AT rojassnina efectoinmunosupresorinvitrodelaslipoproteinasdebajadensidad
AT silvafvictor efectoinmunosupresorinvitrodelaslipoproteinasdebajadensidad
AT kirstenllilian efectoinmunosupresorinvitrodelaslipoproteinasdebajadensidad
AT bustamantecmarcelo efectoinmunosupresorinvitrodelaslipoproteinasdebajadensidad
_version_ 1718435888708452353